BIOCON.BOBIOCON.BOBSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-18.3%
5Y CAGR-12.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-18.3%/yr
vs -13.1%/yr prior
5Y CAGR
-12.1%/yr
Recent deceleration
Acceleration
-5.2pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.66 | +21.8% |
| 2024 | 2.19 | -0.8% |
| 2023 | 2.20 | -54.9% |
| 2022 | 4.88 | -28.1% |
| 2021 | 6.80 | +33.6% |
| 2020 | 5.08 | -23.5% |
| 2019 | 6.65 | -22.4% |
| 2018 | 8.56 | +49.9% |
| 2017 | 5.71 | +101.5% |
| 2016 | 2.83 | - |